LONG-COVID IMPACT ON THE REPRODUCTIVE HEALTH OF WOMEN WITH FERTILITY
Clinical medicine

LONG-COVID IMPACT ON THE REPRODUCTIVE HEALTH OF WOMEN WITH FERTILITY

Published 2024-02-14

Authors:

I.S. Golovchak
O.H. Boichuk
I.M. Kupchak

Abstract:
Reproductive health is a fundamental human right crucial for the health, well-being, and quality of life of individuals, families, communities, society, and the state. To determine the possible impact of COVID-19 on women's reproductive health, we included 80 patients who came to the clinic of reproductive technologies for infertility treatment in a comprehensive examination and were divided into 2 groups. The main group consisted of 60 women after COVID-19 (10 patients with only a male infertility factor were excluded, and one patient refused to participate in the study); the comparison group consisted of 20 patients without a history of COVID-19. The study was carried out using the principles of the Declaration of Helsinki. The research protocol was approved by the institution's Local Ethics Committee, mentioned in the work. Informed consent was obtained from the women for the study. Among patients with infertility, a high frequency of long COVID has been established, the consequences of which are various disorders of somatic and reproductive health, which often arise precisely after suffering from the coronavirus disease. A significantly lower success rate of assisted reproductive technologies programs in these patients was established, which is due to the systemic impact of the coronavirus infection on the woman's body and reproductive function in particular.
Keywords:
reproductive function COVID-19 long COVID infertility assisted reproductive technologies pandemic
References:
  1. Ashour HM, Elkhatib WF, Rahman MM, Elshabrawy HA. Insights into the recent 2019 novel coronavirus (SARS-CoV-2) in light of past human coronavirus outbreaks. Pathogens.2020;9(3): 186.https://dx.doi.org/10.3390/pathogens9030186
  2. Baig AM. Deleterious Outcomes in Long-Hauler COVID-19: The Effects of SARS-CoV-2 on the CNS in Chronic COVID Syndrome. ACS chemical neuroscience.2020;11(24):4017–4020. https://doi.org/10.1021/acschemneuro.0c00725.
  3. Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ open. 2021;11(3): e048391. https://doi.org/10.1136/bmjopen-2020-048391.
  4. Li K, Nowak RA. The role of basigin in reproduction. Reproduction. 2019; Sep 1: REP-19-0268.R1. https://dx.doi.org/10.1530/REP-19-0268.
  5. Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. Journal of medical virology. 2021; 93(2): 1013-1022. https://doi.org/10.1002/jmv.26368.
  6. Hoida NG, Vdovichenko YuP, Moiseienko RA. Role of the legislative body of Ukraine in the monitoring of state healthcare programs. Health of woman. 2017;2(118): 33–35. doi:http: //nbuv.gov.ua/UJRN/Zdzh_2017_2_8.
  7. Huang C, Huang L, Wang Y, Li X, Ren L, Gu X et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet (London, England).2021;397(10270):220–232. https://doi.org/10.1016/S0140-6736(20)32656-8.
  8. Kaminskyi V, Vorobei L, Zhdanovych O, Korniienko S, Kolomiichenko T, Fastovets О. Clinical and genetic determinants of severe course of COVID-19 in pregnant women. REPRODUCTIVE ENDOCRINOLOGY.2022;(65):38–43. https://doi.org/10.18370/2309- 4117.2022.65.38-43.
  9. Kaminskyi V, Tkachenko R, Kaminskyi A, Zhdanovych O, Vorobei L, Kolomiichenko T et al. Therapeutic opportunities for improving the course of coronavirus disease and reducing the frequency of gestional complications. REPRODUCTIVEENDOCRINOLOGY.2021;(62):8–13. https://doi.org/10.18370/2309-4117.2021.62.8-13.
  10. Likhachov V, Shimanska Ya, Akimov O, Vashchenko V, Taranovska O, Zhabchenko I, Kaidashev I. Prophylaxis of decidual CD68+/CD163+ macrophage disbalance in extracorporeal fertilized women. 2023; 9, 10, e21148. Heliyon.
  11. Mironyuk I, Slabkiy G, Shcherbinska О, Bilak-Lukianchuk V. Consequences of the war with the russian federation for the public health of Ukraine. Reproductive health of woman.2022;(8):26–31. https://doi.org/10.30841/2708-8731.8.2022.273291.
  12. Moreno-Pérez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jiménez J et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. The Journal of infection. 2021; 82(3): 378–383. https://doi.org/10.1016/j.jinf.2021.01.004.
  13. Nateghi R, Ghashghaei SH, Shokoohian B, Hezavehei M, Ebrahimi B, Shahverdi AH et al. Female Reproductive Health in SARS-CoV-2 Pandemic Era. International journal of fertilit & sterility. 2021; 15(4): 241–245. https://doi.org/10.22074/IJFS.2021.534956.1164.
Publication:
«World of Medicine and Biology» Vol. 20 No. 87 (2024) , с. 52-55
УДК 616-056.2+618.177+618.177-089.888.11+616.9